This invention belongs to the field of pharmaceutical
crystallization technology and substance separation and purification. It discloses a method for directly crystallizing large-particle, high-purity
ergothioneine crystals from
fermentation broth, and the resulting large-particle, high-purity
ergothioneine crystals. The method uses
ergothioneine fermentation broth as the starting material, dissolving it in a specific
crystallization solvent, and then sequentially undergoing two programmed cooling and
crystal growth processes to directly crystallize and obtain the target product. This method, through the synergistic selection of the
solvent system and control of
crystallization kinetics, simultaneously completes the purification and crystallization of ergothioneine in a
single step, eliminating the complex multi-step pretreatment and purification units found in existing technologies. The obtained product has high purity (≥99.992%), good flowability, particle size >200μm, and
angle of repose <25°, possessing ultra-high purity, ideal physical morphology, and excellent flowability, and can be directly used in downstream formulation production. This invention features a very simple process flow, high production efficiency, low cost, and superior overall product performance, demonstrating significant industrial application value.